Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

FMC vs EMN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

EMN Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

EMN Overall Winner 6-Pillar Tally: FMC 3 – 3 EMN Matrix Metrics: FMC 3 – 7 EMN

As of Nov 17, 2026, Eastman Chemical Company (EMN) is the stronger overall head-to-head candidate over FMC Corporation (FMC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). FMC carries a Unified Composite Score of 46.7/100 (HOLD) at $4.96 (5.5x Forward P/E, -15.7% operating margin), whereas EMN carries 46.4/100 (HOLD) at $62.38 (9.7x Forward P/E, 10.7% operating margin).

  • Technical & Structure Timing Caution: FMC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile EMN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FMC vs EMN
FMC NYSE
FMC Corporation
Chemicals & Allied Products
$4.96
-5.07% 1D
Market Cap $810.5M
TTM Revenue $2.81B
Forward P/E 5.5x
Beta / 30D Vol 0.21β · 132% Vol
Unified Composite Score
46.7 / 100 HOLD
Tech 33.0 Fund 53.0 Flow 67.0 Mom 74.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -23.5%), weak momentum, RSI 36
RSI-14: 36.0 · SMA20: $5.39 · SMA50: $7.64
EMN NYSE Head-to-Head Winner
Eastman Chemical Company
Plastic Materials, Synth Resins & Nonvulcan Elastomers
$62.38
-1.76% 1D
Market Cap $7.4B
TTM Revenue $9.05B
Forward P/E 9.7x
Beta / 30D Vol 0.80β · 28% Vol
Unified Composite Score
46.4 / 100 HOLD
Tech 41.0 Fund 53.0 Flow 60.0 Mom 70.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 39
RSI-14: 39.0 · SMA20: $65.52 · SMA50: $65.24

6-Pillar Scorecard Institutional Category Breakdown (FMC 3 – 3 EMN)

Columns: Metric · FMC · EMN
1. Valuation Multiples FMC
Forward P/E 5.5x 9.7x
Trailing P/E 4.2x 11.6x
PEG Ratio 0.46x 0.64x
EV / Revenue 1.5x 1.3x
2. Growth & Scale EMN
Revenue Growth (YoY) -80.5% +8.3%
Earnings Growth (YoY) -77.6% +265.0%
TTM Revenue (USD) $2.81B $9.05B
Market Cap $810.5M $7.4B
3. Profitability & Quality EMN
Gross Margin 17.6% 20.3%
Operating Margin -15.7% 10.7%
Net Profit Margin -151.2% 6.9%
Return on Equity (ROE) -218.9% 10.3%
4. Balance Sheet & Cash Flow EMN
Cash Generation (TTM) $296M $1.50B EBITDA
Cash Flow Margin 10.5% 16.6% EBITDA Mgn
Net Cash / Leverage $3.44B Net Debt $4.45B Net Debt (0.83x D/E)
Dividend Yield 6.32% 5.12%
5. Options & Positioning FMC
Options Structure Phase SURGE CONSOLIDATION
Current IV / %ile 104.3% (100th %ile) 38.5% (50th %ile)
Put/Call OI Skew 0.82x (Call-Skewed) 0.22x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat FMC
OpEx & R&D Intensity 33.3% of Rev ($937M) 9.6% of Rev ($869M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Agricultural Inputs Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FMC (3) vs EMN (7)
Institutional Metric FMC EMN Criterion Row Edge
Market Capitalization
Scale
$810.5M $7.4B Larger Scale EMN
Trailing P/E Ratio
Valuation
4.2x 11.6x Lower Multiple FMC
Forward P/E Ratio
Valuation
5.5x 9.7x Lower Multiple FMC
Revenue Growth (YoY)
Growth
-80.5% +8.3% Higher Growth EMN
Operating Margin (TTM)
Profitability
-15.7% 10.7% Higher Margin EMN
Net Profit Margin
Profitability
-151.2% 6.9% Higher Margin EMN
Return on Equity (ROE)
Capital Efficiency
-218.9% 10.3% Higher ROE EMN
52-Week Range Position
Momentum
4% ($4–$18) 23% ($56–$83) Stronger Trend EMN
Beta / 30D Volatility
Risk Regime
0.21β · 132% Vol 0.80β · 28% Vol Lower Realized Risk EMN
Unified Institutional Score
Composite Signal
46.7 / 100 (HOLD) 46.4 / 100 (HOLD) Higher Composite FMC
Trailing 12M Revenue (USD)
Operating Scale
$2.81B $9.05B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.6% 20.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.46x PEG · 1.5x EV/Rev 0.64x PEG · 1.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$296M ($3.44B Net Debt) $1.50B EBITDA ($4.45B Net Debt (0.83x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EMN +7.2 pp
FMC: -7.37% · EMN: -0.17%
3M Horizon EMN +37.06 pp
FMC: -54.07% · EMN: -17.01%
6M Horizon EMN +52.62 pp
FMC: -61.09% · EMN: -8.47%
1Y Horizon EMN +67.81 pp
FMC: -64.28% · EMN: +3.53%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period FMC Revenue EMN Revenue FMC Op. Margin EMN Op. Margin Margin Leader
FY2018 $4.29B $10.2B 17.3% 10.6% FMC
FY2019 $4.61B $9.27B 17.8% 8.2% FMC
FY2020 $4.64B $8.47B 19.3% 5.6% FMC
FY2021 $5.05B $10.5B 20.5% 8.2% FMC
FY2022 $5.80B $10.6B 19.7% 7.5% FMC
FY2023 $4.49B $9.21B 12.4% 9.7% FMC
FY2024 $4.25B $9.38B 11.9% 9.6% FMC
FY2025 $3.47B $8.75B -47.0% 5.4% EMN

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FMC SURGE
11d in phase · OBV NEUTRAL
Current IV 104.3%
IV Percentile 100th %ile
Put/Call OI Skew 0.82x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FMC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EMN CONSOLIDATION
138d in phase · OBV NEUTRAL
Current IV 38.5%
IV Percentile 50th %ile
Put/Call OI Skew 0.22x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact EMN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $63.49 · IV 36.2%

EMN Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($6,349)

Compare $6,349 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 36.2% ATM IV.

PUT-WALL MONTHLY INCOME Liq B

Dec 18 $60 / $55 Bull Put Spread

Sell 1x $60P · Buy 1x $55P · 31d

Net Entry $93 Credit
Max Credit / Yield +$93 (+22.9% RoM)
Max Risk / Buffer -7.0% Cushion ($407 Mgn)
5d Edge & Liquidity 73% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $65 / $60 Bear Put Spread

Buy 1x $65P · Sell 1x $60P · 31d

Net Entry $200 Debit
T+5d @ -5% Drop +$100 (+50%)
Max Risk / Buffer $200 Capped
5d Edge & Liquidity 1.0x R:R · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FMC Moat Profile Cyclical / Execution-Driven Positioning
Agricultural Inputs Operator
Competes within the Agricultural Inputs value chain with $810.5M market capitalization and -15.7% operating margin.
OpEx & R&D Reinvestment 33.3% of Rev ($937M)
90D Engineering Disclosures 0 Published
EMN Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $7.4B market capitalization and 10.7% operating margin.
OpEx & R&D Reinvestment 9.6% of Rev ($869M)
90D Engineering Disclosures 0 Published

Investor FAQ FMC vs EMN Key Questions & Quantitative Answers

As of Nov 17, 2026, Eastman Chemical Company (EMN) is the stronger overall head-to-head candidate over FMC Corporation (FMC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). FMC carries a Unified Composite Score of 46.7/100 (HOLD) at $4.96 (5.5x Forward P/E, -15.7% operating margin), whereas EMN carries 46.4/100 (HOLD) at $62.38 (9.7x Forward P/E, 10.7% operating margin). Technical & Structure Timing Caution: FMC is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.0); meanwhile EMN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

EMN leads the Growth & Scale pillar: FMC posts -80.5% YoY revenue growth and -77.6% YoY earnings growth on $2.81B TTM revenue (17.6% gross margin, -15.7% operating margin), compared with EMN at +8.3% YoY revenue growth and +265.0% YoY earnings growth on $9.05B TTM revenue (20.3% gross margin, 10.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), FMC cumulative revenue shifted -19.1% while EMN shifted -13.8%. In operating R&D and SG&A reinvestment, FMC deploys 33.3% of Rev ($937M) (0 90-day corporate R&D disclosures) versus 9.6% of Rev ($869M) (0 disclosures) for EMN.

FMC screens cheaper on headline valuation multiples. FMC trades at 5.5x Forward P/E, 4.2x Trailing P/E, 0.46x PEG, and 1.5x EV/Revenue (10.5% FCF margin), whereas EMN trades at 9.7x Forward P/E, 11.6x Trailing P/E, 0.64x PEG, and 1.3x EV/Revenue (16.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FMC (-218.9% ROE) versus EMN (10.3% ROE) capital efficiency.

In options market volatility and institutional positioning, FMC carries 104.3% implied volatility (100th %ile, Extreme (>80th %ile)), a 0.82x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (0.21β · 132% Vol realized risk). By comparison, EMN carries 38.5% implied volatility (50th %ile, Balanced (25th–60th %ile)), a 0.22x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.80β · 28% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.